Protara Therapeutics (TARA) Prepaid Assets (2013 - 2026)
Protara Therapeutics (TARA) recorded quarterly Prepaid Assets of $2.0 million in Q1 2026, up 3038.46% quarter-over-quarter from $65000.0 in Q4 2025, and up 12650.0% on a YoY basis from N/an in Q1 2025.
Protara Therapeutics (TARA) Prepaid Assets (2013 - 2026) Analysis & Trends
Protara Therapeutics' Prepaid Assets history runs 14 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 12650.0% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (up 12650.0% YoY), while the FY2025 annual figure was $65000.0, down 89.55% from the prior year.
- Prepaid Assets was $2.0 million for Q1 2026 at Protara Therapeutics, up from $65000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.1 million in Q1 2022 to a low of $16000.0 in Q1 2025.
- Historically, Prepaid Assets has averaged $1.5 million across 5 years, with a median of $1.8 million in 2022.
- The sharpest annual moves came in 2023 and 2026: Prepaid Assets tumbled 97.92% in 2023, then surged 12650.0% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $1.8 million in 2022, then sank by 97.92% to $37000.0 in 2023, then surged by 1581.08% to $622000.0 in 2024, then tumbled by 89.55% to $65000.0 in 2025, then jumped by 3038.46% to $2.0 million in 2026.
- The last three Prepaid Assets figures came in at $2.0 million (Q1 2026), $65000.0 (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Protara Therapeutics | 216.35 Mn | 216.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | 65,000.00 |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | 2.88 Mn |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 622,000.00 |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 196,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 374,000.00 |
| Jun 30, 2023 | 543,000.00 |
| Mar 31, 2023 | 127,000.00 |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 2.35 Mn |
| Jun 30, 2022 | 2.63 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 1.94 Mn |
| Jun 30, 2021 | 3.15 Mn |